These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 30861164)
1. CCEPR is a novel clinical biomarker for prognosis and regulates cell proliferation through PCNA in osteosarcoma. Teng J; Guo X; Wang H J Cell Biochem; 2019 Aug; 120(8):12796-12802. PubMed ID: 30861164 [TBL] [Abstract][Full Text] [Related]
2. Expression of the cervical carcinoma expressed PCNA regulatory (CCEPR) long noncoding RNA is driven by the human papillomavirus E6 protein and modulates cell proliferation independent of PCNA. Sharma S; Munger K Virology; 2018 May; 518():8-13. PubMed ID: 29427865 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of long non-coding RNA CCEPR is associated with poor prognosis and promotes tumorigenesis in urothelial bladder carcinoma. Zhan Y; Li Y; Guan B; Chen X; Chen Z; He A; He S; Gong Y; Peng D; Liu Y; Cai Z; Li X; Zhou L Oncotarget; 2017 Jul; 8(27):44326-44334. PubMed ID: 28574830 [TBL] [Abstract][Full Text] [Related]
4. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2. Wang Z; Tan M; Chen G; Li Z; Lu X IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757 [TBL] [Abstract][Full Text] [Related]
5. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma. Chen S; Li W; Guo A Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944201 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of long non‑coding RNA CCEPR is associated with poor prognosis and contributes to the progression of ovarian cancer through regulating the Wnt/β‑catenin signaling pathway. Chen Z; Zhu Y; Fan X; Liu Y; Feng Q Mol Med Rep; 2020 Apr; 21(4):1950-1958. PubMed ID: 32319633 [TBL] [Abstract][Full Text] [Related]
7. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma. Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852 [TBL] [Abstract][Full Text] [Related]
8. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma. Ruan R; Zhao XL Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA. Yang M; Zhai X; Xia B; Wang Y; Lou G Tumour Biol; 2015 Sep; 36(10):7615-22. PubMed ID: 25921283 [TBL] [Abstract][Full Text] [Related]
10. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3. Dong Z; Wang Y Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678 [TBL] [Abstract][Full Text] [Related]
11. Upregulation of cervical carcinoma expressed PCNA regulatory long non-coding RNA promotes esophageal squamous cell carcinoma progression. Wang X; Zhou L; Zhang H; Ou H; Long W; Liu X Oncol Lett; 2020 Nov; 20(5):142. PubMed ID: 32934710 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of lncRNA CCEPR suppresses colorectal cancer progression. Duan Y; Fang Z; Shi Z; Zhang L Exp Ther Med; 2019 Nov; 18(5):3534-3542. PubMed ID: 31602230 [TBL] [Abstract][Full Text] [Related]
13. Role of taurine upregulated gene 1 as a predictor of poor outcome in osteosarcoma. Wang Q; Chen Q J Cancer Res Ther; 2018 Jun; 14(Supplement):S405-S409. PubMed ID: 29970697 [TBL] [Abstract][Full Text] [Related]
14. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma. Tian ZZ; Guo XJ; Zhao YM; Fang Y Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma. Ye H; Lin J; Yao X; Li Y; Lin X; Lu H Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma. Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2. Gu W; Zhang E; Song L; Tu L; Wang Z; Tian F; Aikenmu K; Chu G; Zhao J Biomed Pharmacother; 2018 Oct; 106():890-895. PubMed ID: 30119259 [TBL] [Abstract][Full Text] [Related]
18. Elevated long noncoding RNA HAGLROS expression correlates with clinical progression and prognosis in osteosarcoma. Wu PF; Dai ZT; Liu WD; Zhao ZX; Kong YH Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1428-1433. PubMed ID: 30840263 [TBL] [Abstract][Full Text] [Related]
19. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2. Huo Y; Li Q; Wang X; Jiao X; Zheng J; Li Z; Pan X Oncotarget; 2017 Jul; 8(29):46993-47006. PubMed ID: 28388584 [TBL] [Abstract][Full Text] [Related]
20. High expression of long non-coding RNA XIST in osteosarcoma is associated with cell proliferation and poor prognosis. Li GL; Wu YX; Li YM; Li J Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2829-2834. PubMed ID: 28682435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]